Related Experiment Videos
Methicillin-resistant staphylococci: genetics and mechanisms of resistance
1Medical Service, San Francisco General Hospital, California.
Antimicrobial Agents and Chemotherapy
|July 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs.
The Journal of infectious diseases·2017
Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
Antimicrobial agents and chemotherapy·2016
Methicillin-resistant Staphylococcus aureus. Mechanisms of resistance and implications for treatment.
Postgraduate medicine·2009
Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis.
Antimicrobial agents and chemotherapy·2009
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Marine-derived Bioactive Compounds: A Promising Frontier against Multidrug-resistant Microbial Infections.
Mini reviews in medicinal chemistry·2026